These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21406418)

  • 21. Oversulfated heparin by-products induce thrombin generation in human plasmas through contact system activation.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Hourcade DE; Liszewski MK; Atkinson JP; Hong Lu ; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):244-50. PubMed ID: 20547553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contaminated heparin preparations, severe adverse events and the contact system.
    Ramacciotti E; Wahi R; Messmore HL
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):489-91. PubMed ID: 18815138
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin comes clean.
    Schwartz LB
    N Engl J Med; 2008 Jun; 358(23):2505-9. PubMed ID: 18525048
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Delayed intracutaneous test reaction in heparin intolerance].
    Wurpts G; Merk HF
    Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
    Alban S; Lühn S; Schiemann S
    Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contaminated heparin associated with adverse clinical events and activation of the contact system.
    Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
    N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
    McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
    Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
    Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
    [No Abstract]   [Full Text] [Related]  

  • 31. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from the contamination of heparin.
    Liu H; Zhang Z; Linhardt RJ
    Nat Prod Rep; 2009 Mar; 26(3):313-21. PubMed ID: 19240943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in quantitative polymerase chain reaction applied to control the quality of heparins.
    Auguste C; Dereux S; Martinez C; Anger P
    Anal Bioanal Chem; 2011 Jan; 399(2):747-55. PubMed ID: 20931175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach.
    Kellenbach E; Sanders K; Michiels PJ; Girard FC
    Anal Bioanal Chem; 2011 Jan; 399(2):621-8. PubMed ID: 21069304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass balance analysis of contaminated heparin product.
    Liu Z; Xiao Z; Masuko S; Zhao W; Sterner E; Bansal V; Fareed J; Dordick J; Zhang F; Linhardt RJ
    Anal Biochem; 2011 Jan; 408(1):147-56. PubMed ID: 20850409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Analyst; 2000 May; 125(5):933-8. PubMed ID: 10885058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tainted heparin crisis tested FDA's investigative skills.
    Lavine G
    Am J Health Syst Pharm; 2009 Feb; 66(3):210-1. PubMed ID: 19179633
    [No Abstract]   [Full Text] [Related]  

  • 38. The heparin recall of 2008.
    Hedlund KD; Coyne DP; Sanford DM; Huddelson J
    Perfusion; 2013 Jan; 28(1):61-5. PubMed ID: 23042900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chemical killer unmasked.
    Perkel JM
    Anal Chem; 2008 Jul; 80(13):4789-90. PubMed ID: 18609746
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthetic heparin analogue and prothrombin time.
    Kakkar VV; Djazaeri B; Scully M; Weerasinghe K
    Lancet; 1981 May; 1(8230):1167. PubMed ID: 6112524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.